Shares of Healthways Inc. (NASDAQ:HWAY) have been given an average recommendation of “Buy” by the seven ratings firms that are presently covering the firm. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $26.50.

Several research analysts have commented on the stock. Piper Jaffray Cos. boosted their price target on shares of Healthways from $15.00 to $25.50 and gave the stock an “overweight” rating in a report on Wednesday, August 10th. Zacks Investment Research upgraded shares of Healthways from a “hold” rating to a “buy” rating and set a $20.00 price target for the company in a report on Monday, August 8th. Jefferies Group boosted their price target on shares of Healthways from $13.00 to $18.50 and gave the stock a “hold” rating in a report on Thursday, August 4th. Barclays PLC upgraded shares of Healthways from an “underweight” rating to an “equal weight” rating and boosted their price target for the stock from $12.00 to $27.00 in a report on Monday, August 22nd. Finally, FBR & Co boosted their price target on shares of Healthways from $16.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, August 10th.

In related news, Director Mary Jane England sold 3,816 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $24.78, for a total value of $94,560.48. Following the completion of the sale, the director now owns 39,068 shares in the company, valued at approximately $968,105.04. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 14.01% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently added to or reduced their stakes in HWAY. Prudential Financial Inc. increased its stake in Healthways by 3.6% in the first quarter. Prudential Financial Inc. now owns 73,984 shares of the company’s stock valued at $746,000 after buying an additional 2,600 shares during the period. BlackRock Fund Advisors increased its stake in Healthways by 1.7% in the first quarter. BlackRock Fund Advisors now owns 2,251,011 shares of the company’s stock valued at $22,713,000 after buying an additional 37,357 shares during the period. Royce & Associates LP increased its stake in Healthways by 13.4% in the first quarter. Royce & Associates LP now owns 903,204 shares of the company’s stock valued at $9,113,000 after buying an additional 106,500 shares during the period. Bogle Investment Management L P DE acquired a new stake in Healthways during the first quarter valued at approximately $831,000. Finally, Jacobs Levy Equity Management Inc. acquired a new stake in Healthways during the first quarter valued at approximately $416,000. Hedge funds and other institutional investors own 92.60% of the company’s stock.

Shares of Healthways (NASDAQ:HWAY) opened at 25.92 on Friday. The firm’s market cap is $952.25 million. The company’s 50-day moving average is $25.37 and its 200 day moving average is $16.75. Healthways has a 52-week low of $9.18 and a 52-week high of $27.30.

Healthways (NASDAQ:HWAY) last posted its quarterly earnings results on Tuesday, August 9th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.01 by $0.53. Healthways had a negative net margin of 31.32% and a positive return on equity of 8.83%. The company earned $125 million during the quarter, compared to analysts’ expectations of $186.88 million. During the same quarter in the previous year, the business posted $0.11 EPS. The firm’s revenue was up 10.2% on a year-over-year basis. On average, analysts expect that Healthways will post $2.11 earnings per share for the current fiscal year.

About Healthways

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

5 Day Chart for NASDAQ:HWAY

Receive News & Stock Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related stocks with our FREE daily email newsletter.